DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
DANAHER CORP /DE/
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026
$224.43−4.61 (-2.01%)
Close on Oct 19, 2026
- Market cap
- $158.81B
- P/E (TTM)
- 39.9
- Dividend yield
- –
DANAHER CORP /DE/ revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology | $7.55B | $7.48B | $7.29B | $7.13B | $6.98B | $6.85B | $6.76B | $6.65B | $6.66B | $6.83B | $7.17B | – | 30.1% | +8.1% |
| Diagnostics | – | – | – | $9.86B | $9.76B | $9.71B | $9.79B | $9.87B | $9.76B | $9.73B | $9.58B | $9.83B | – | – |
| Environmental & Applied Solutions | – | – | – | – | – | – | – | – | – | – | – | $4.92B | – | – |
| Life Sciences | – | – | – | $7.28B | $7.27B | $7.26B | $7.33B | $7.23B | $7.15B | $7.18B | $7.14B | $7.16B | – | – |
| Operating income | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology | $1.98B | $1.96B | $1.86B | $1.83B | $1.87B | $1.80B | $1.69B | $1.59B | $1.62B | $1.64B | $1.91B | – | +6.0% |
| Diagnostics | – | – | – | $2.56B | $2.51B | $2.51B | $2.63B | $2.77B | $2.69B | $2.56B | $2.41B | $2.63B | – |
| Environmental & Applied Solutions | – | – | – | – | – | – | – | – | – | – | – | $1.19B | – |
| Life Sciences | – | – | – | $560.00M | $373.00M | $845.00M | $879.00M | $738.00M | $1.02B | $1.12B | $1.21B | $1.37B | – |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Recurring revenue | $20.57B | $20.34B | $20.13B | $19.91B | $19.67B | $19.39B | $19.37B | $19.25B | $18.91B | $18.82B | $18.68B | $16.96B | 81.9% | +4.6% |
| Nonrecurring revenue | $4.54B | $4.44B | $4.44B | $4.36B | $4.35B | $4.43B | $4.51B | $4.50B | $4.66B | $4.92B | $5.21B | $4.07B | 18.1% | +4.4% |
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | $10.29B | $10.25B | $10.36B | $10.37B | $10.25B | $10.25B | $10.30B | $10.31B | $10.23B | $10.14B | $9.96B | $8.69B | 41.0% | +0.4% |
| High-growth markets | $7.37B | $7.11B | $7.02B | $6.91B | $6.87B | $6.87B | $6.87B | – | – | – | – | – | 29.4% | +7.3% |
| Western Europe | $6.19B | $6.16B | $5.94B | $5.74B | $5.66B | $5.48B | $5.46B | $5.38B | $5.26B | $5.36B | $5.47B | $4.85B | 24.7% | +9.3% |
| Other developed markets | $1.26B | $1.26B | $1.25B | $1.25B | $1.23B | $1.23B | $1.25B | – | – | – | – | – | 5.0% | +2.2% |
| High-growth markets | – | – | – | – | – | – | – | $6.81B | $6.84B | $6.98B | $7.19B | $6.28B | – | – |
| Other developed markets | – | – | – | – | – | – | – | $1.24B | $1.25B | $1.25B | $1.27B | $1.20B | – | – |
From the segment and revenue-disaggregation notes of Danaher's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.